Matches in Wikidata for { <http://www.wikidata.org/entity/Q71691653> ?p ?o ?g. }
Showing items 1 to 58 of
58
with 100 items per page.
- Q71691653 description "artículu científicu espublizáu en mayu de 1995" @default.
- Q71691653 description "im Mai 1995 veröffentlichter wissenschaftlicher Artikel" @default.
- Q71691653 description "scientific article published on 01 May 1995" @default.
- Q71691653 description "wetenschappelijk artikel" @default.
- Q71691653 description "наукова стаття, опублікована в травні 1995" @default.
- Q71691653 name "Dose escalation of paclitaxel with high-dose cyclophosphamide, with analysis of progenitor-cell mobilization and hematologic support of advanced ovarian cancer patients receiving rapidly sequenced high-dose carboplatin/cyclophosphamide courses" @default.
- Q71691653 name "Dose escalation of paclitaxel with high-dose cyclophosphamide, with analysis of progenitor-cell mobilization and hematologic support of advanced ovarian cancer patients receiving rapidly sequenced high-dose carboplatin/cyclophosphamide courses" @default.
- Q71691653 type Item @default.
- Q71691653 label "Dose escalation of paclitaxel with high-dose cyclophosphamide, with analysis of progenitor-cell mobilization and hematologic support of advanced ovarian cancer patients receiving rapidly sequenced high-dose carboplatin/cyclophosphamide courses" @default.
- Q71691653 label "Dose escalation of paclitaxel with high-dose cyclophosphamide, with analysis of progenitor-cell mobilization and hematologic support of advanced ovarian cancer patients receiving rapidly sequenced high-dose carboplatin/cyclophosphamide courses" @default.
- Q71691653 prefLabel "Dose escalation of paclitaxel with high-dose cyclophosphamide, with analysis of progenitor-cell mobilization and hematologic support of advanced ovarian cancer patients receiving rapidly sequenced high-dose carboplatin/cyclophosphamide courses" @default.
- Q71691653 prefLabel "Dose escalation of paclitaxel with high-dose cyclophosphamide, with analysis of progenitor-cell mobilization and hematologic support of advanced ovarian cancer patients receiving rapidly sequenced high-dose carboplatin/cyclophosphamide courses" @default.
- Q71691653 P1433 Q71691653-2030DBC6-1A79-4391-9745-EE5F09B8E3F8 @default.
- Q71691653 P1476 Q71691653-E784CB82-EA86-41F9-83EF-C1D1BAFB9207 @default.
- Q71691653 P2093 Q71691653-07ACF3A5-194F-460E-8546-E67C4134DA25 @default.
- Q71691653 P2093 Q71691653-0DA11279-2896-4D98-92FE-3F62448D9F7B @default.
- Q71691653 P2093 Q71691653-33B685EB-8548-4A27-8481-7ADB264FC451 @default.
- Q71691653 P2093 Q71691653-3FFB2C95-44A1-4072-9614-10108228AF4F @default.
- Q71691653 P2093 Q71691653-7247C486-68F9-4A09-BD7E-73287CD56E63 @default.
- Q71691653 P2093 Q71691653-78C39FDF-17D7-4083-8FF9-B64A88127EAC @default.
- Q71691653 P2093 Q71691653-816661CD-50E7-463F-97FD-8754D859ADAC @default.
- Q71691653 P2093 Q71691653-A4608704-D15B-4FF7-AB25-249E3945B969 @default.
- Q71691653 P2093 Q71691653-AAA514C9-2D37-4CDD-90D9-B9DC22D41022 @default.
- Q71691653 P2093 Q71691653-C886E73D-9C2C-4571-A17A-564C1B672333 @default.
- Q71691653 P304 Q71691653-CD4D6B55-3498-41F4-9AF9-05312135B356 @default.
- Q71691653 P31 Q71691653-8946BA77-1681-416E-BE5E-D1386989344C @default.
- Q71691653 P356 Q71691653-026551DA-3737-4C67-8085-8BBEC53BCFF2 @default.
- Q71691653 P407 Q71691653-A9CD6D79-2F5E-4B71-9180-2CE1C045C894 @default.
- Q71691653 P433 Q71691653-4968231B-C4F2-43AD-896B-038DE6F4B374 @default.
- Q71691653 P478 Q71691653-AEC88739-F5B7-4DC7-BCA6-A1BAA34D0901 @default.
- Q71691653 P577 Q71691653-BDD3DDB5-300B-4BDE-BB6B-079ACDD22D03 @default.
- Q71691653 P698 Q71691653-5BEE2D9E-7B02-403C-A8AE-74B52550DAD6 @default.
- Q71691653 P921 Q71691653-CA8F4A35-B0F4-4C46-80FA-83D2C2803E6D @default.
- Q71691653 P921 Q71691653-FC40BD9F-1391-41B7-BD06-3E4AEE24FD71 @default.
- Q71691653 P356 JCO.1995.13.5.1160 @default.
- Q71691653 P698 7537799 @default.
- Q71691653 P1433 Q400292 @default.
- Q71691653 P1476 "Dose escalation of paclitaxel with high-dose cyclophosphamide, with analysis of progenitor-cell mobilization and hematologic support of advanced ovarian cancer patients receiving rapidly sequenced high-dose carboplatin/cyclophosphamide courses" @default.
- Q71691653 P2093 "C Bengala" @default.
- Q71691653 P2093 "D Fennelly" @default.
- Q71691653 P2093 "D Spriggs" @default.
- Q71691653 P2093 "J Curtin" @default.
- Q71691653 P2093 "J Schneider" @default.
- Q71691653 P2093 "L Reich" @default.
- Q71691653 P2093 "M A Moore" @default.
- Q71691653 P2093 "R Barakat" @default.
- Q71691653 P2093 "T Hakes" @default.
- Q71691653 P2093 "W Hoskins" @default.
- Q71691653 P304 "1160-1166" @default.
- Q71691653 P31 Q13442814 @default.
- Q71691653 P356 "10.1200/JCO.1995.13.5.1160" @default.
- Q71691653 P407 Q1860 @default.
- Q71691653 P433 "5" @default.
- Q71691653 P478 "13" @default.
- Q71691653 P577 "1995-05-01T00:00:00Z" @default.
- Q71691653 P698 "7537799" @default.
- Q71691653 P921 Q172341 @default.
- Q71691653 P921 Q423762 @default.